{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:27:08Z","timestamp":1792193228494,"version":"4.4.0"},"reference-count":84,"publisher":"Walter de Gruyter GmbH","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Short stature, ovarian dysgenesis, infertility, and cardiovascular malformations are classic features in Turner syndrome (TS), but the phenotypical spectrum is wide. Through early diagnosis and appropriate treatment, TS patients have a chance to achieve satisfactory adult height and sexual development. The doses of recombinant growth hormone (rGH) used are usually higher than the substitution dose. The safety aspects of this therapy are very important, especially in terms of the cardiovascular system. The presented study aimed to analyze how the rGH therapy may influence the cardiovascular system in TS based on current literature data. We conducted a systematic search for studies related to TS, cardiovascular system, and rGH therapy. The results show that rGH seems to have a positive effect on lipid parameters, reducing the risk of ischemic disease. It is additionally optimized by estradiol therapy. Although rGH may increase insulin resistance, the metabolic derangement is rare, probably due to lower fat content and an increase in lean body mass. Several studies showed that rGH treatment could cause aorta widening or increase the aorta growth rate. IGF-1 can be independently associated with increased aortic diameters. The studies analyzing the impact of GH on blood pressure show conflicting data. The proper cardiovascular imaging before and during rGH treatment and detecting the known risk factors for aorta dissection in every individual is very important. The long-term effects of growth hormone treatment on the heart and arteries are still not available and clearly estimated and have to be monitored in the future.<\/jats:p>","DOI":"10.1515\/jpem-2020-0266","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T20:49:16Z","timestamp":1606769356000},"page":"1363-1372","source":"Crossref","is-referenced-by-count":15,"title":["The influence of growth hormone therapy on the cardiovascular system in Turner syndrome"],"prefix":"10.1515","volume":"33","author":[{"given":"Kamil","family":"Dyrka","sequence":"first","affiliation":[{"name":"Student Scientific Society of Pediatric Endocrinology , Poznan University of Medical Sciences , Poznan , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Rozkiewicz","sequence":"additional","affiliation":[{"name":"Student Scientific Society of Pediatric Endocrinology , Poznan University of Medical Sciences , Poznan , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-134X","authenticated-orcid":false,"given":"Monika","family":"Obara-Moszynska","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Rheumatology , Poznan University of Medical Sciences , Poznan , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8862-6937","authenticated-orcid":false,"given":"Marek","family":"Niedziela","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Rheumatology , Poznan University of Medical Sciences , Poznan , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"2023040101055754481_j_jpem-2020-0266_ref_001_w2aab3b7c65b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Bondy, CA. Turner syndrome study group care of girls and women with turner syndrome: a guideline of the turner syndrome study group. J Clin Endocrinol Metab 2007;92:10\u201325. https:\/\/doi.org\/10.1210\/jc.2006-1374.","DOI":"10.1210\/jc.2006-1374"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_002_w2aab3b7c65b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Cui, X, Cui, Y, Shi, L, Luan, J, Zhou, X, Han, J. A basic understanding of Turner syndrome: incidence, complications, diagnosis, and treatment. Intractable Rare Dis Res 2018;7:223\u20138. https:\/\/doi.org\/10.5582\/irdr.2017.01056.","DOI":"10.5582\/irdr.2017.01056"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_003_w2aab3b7c65b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Viuff, MH, Stochholm, K, Uldbjerg, N, Nielsen, BB, Danish Fetal Medicine Study Group, Gravholt, CH. Only a minority of sex chromosome abnormalities are detected by a national prenatal screening program for Down syndrome. Hum Reprod (Oxford, England) 2015;30:2419\u201326. https:\/\/doi.org\/10.1093\/humrep\/dev192.","DOI":"10.1093\/humrep\/dev192"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_004_w2aab3b7c65b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Stochholm, K, Juul, S, Juel, K, Naeraa, RW, Gravholt, CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006;91:3897\u2013902. https:\/\/doi.org\/10.1210\/jc.2006-0558.","DOI":"10.1210\/jc.2006-0558"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_005_w2aab3b7c65b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Viuff, MH, Berglund, A, Juul, S, Andersen, NH, Stochholm, K, Gravholt, CH. Sex hormone replacement therapy in Turner Syndrome - impact on morbidity and mortality. J Clin Endocrinol Metab 2019;105:468\u201378. https:\/\/doi.org\/10.1210\/clinem\/dgz039.","DOI":"10.1210\/clinem\/dgz039"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_006_w2aab3b7c65b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Elsheikh, M, Dunger, DB, Conway, GS, Wass, JA. Turner\u2019s syndrome in adulthood. Endocr Rev 2002;23:120\u201340. https:\/\/doi.org\/10.1210\/edrv.23.1.0457.","DOI":"10.1210\/edrv.23.1.0457"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_007_w2aab3b7c65b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Gravholt, CH, Landin-Wilhelmsen, K, Stochholm, K, Hjerrild, BE, Ledet, T, Djurhuus, CB, et al.. Clinical and epidemiological description of aortic dissection in Turner\u2019s syndrome. Cardiol Young 2006;16:430\u20136. https:\/\/doi.org\/10.1017\/S1047951106000928.","DOI":"10.1017\/S1047951106000928"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_008_w2aab3b7c65b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Stochholm, K, Hjerrild, B, Mortensen, KH, Juul, S, Frydenberg, M, Gravholt, CH. Socioeconomic parameters and mortality in Turner syndrome. Eur J Endocrinol 2012;166:1013\u20139. https:\/\/doi.org\/10.1530\/EJE-11-1066.","DOI":"10.1530\/EJE-11-1066"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_009_w2aab3b7c65b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Gravholt, CH. Medical problems of adult Turner\u2019s syndrome. Horm Res 2001;56:44\u201350. https:\/\/doi.org\/10.1159\/000048134.","DOI":"10.1159\/000048134"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_010_w2aab3b7c65b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Apperley, L, Das, U, Ramakrishnan, R, Dharmaraj, P, Blair, J, Didi, M, et al. Mode of clinical presentation and delayed diagnosis of Turner syndrome: a single Centre UK study. Int J Pediatr Endocrinol 2018;2018:4. https:\/\/doi.org\/10.1186\/s13633-018-0058-1.","DOI":"10.1186\/s13633-018-0058-1"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_011_w2aab3b7c65b1b6b1ab2b1c11Aa","unstructured":"SA, K. Children with physical disabilities and health impairments. 10th ed. Boston= H Mifflin Company College Division; 2002. pp. 492\u2013534."},{"key":"2023040101055754481_j_jpem-2020-0266_ref_012_w2aab3b7c65b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Ramos-Lev\u00ed, AM, Marazuela, M. Bringing cardiovascular comorbidities in acromegaly to an update. How should we diagnose and manage them?. Front Endocrinol (Lausanne) 2019;10:120. https:\/\/doi.org\/10.3389\/fendo.2019.00120.","DOI":"10.3389\/fendo.2019.00120"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_013_w2aab3b7c65b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Colao, A, Ferone, D, Marzullo, P, Lombardi, G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004;25:102\u201352. https:\/\/doi.org\/10.1210\/er.2002-0022.","DOI":"10.1210\/er.2002-0022"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_014_w2aab3b7c65b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Huang, Y, Cai, X, Mai, W, Li, M, Hu, Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ 2016;355:i5953. https:\/\/doi.org\/10.1136\/bmj.i5953.","DOI":"10.1136\/bmj.i5953"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_015_w2aab3b7c65b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Morales-Demori, R. Congenital heart disease and cardiac procedural outcomes in patients with trisomy 21 and Turner syndrome. Congenit Heart Dis 2017;12:820\u20137. https:\/\/doi.org\/10.1111\/chd.12521.","DOI":"10.1111\/chd.12521"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_016_w2aab3b7c65b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Mortensen, KH, Hjerrild, BE, Andersen, NH, S\u00f8rensen, KE, H\u00f8rlyck, A, Pedersen, EM, et al. Abnormalities of the major intrathoracic arteries in Turner syndrome as revealed by magnetic resonance imaging. Cardiol Young 2010;20:191\u2013200. https:\/\/doi.org\/10.1017\/S1047951110000041.","DOI":"10.1017\/S1047951110000041"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_017_w2aab3b7c65b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Ho, VB, Bakalov, VK, Cooley, M, Van, PL, Hood, MN, Burklow, TR, et al. Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 2004;110:1694\u2013700. https:\/\/doi.org\/10.1161\/01.CIR.0000142290.35842.B0.","DOI":"10.1161\/01.CIR.0000142290.35842.B0"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_018_w2aab3b7c65b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Mortensen, KH, Andersen, NH, Gravholt, CH. Cardiovascular phenotype in turner syndrome\u2014integrating cardiology, genetics, and endocrinology. Endocr Rev 2012;33:677\u2013714. https:\/\/doi.org\/10.1210\/er.2011-1059.","DOI":"10.1210\/er.2011-1059"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_019_w2aab3b7c65b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Viuff, MH, Trolle, C, Wen, J, Jensen, JM, N\u00f8rgaard, BL, Gutmark, EJ, et al. Coronary artery anomalies in turner syndrome. J Cardiovasc Comput Tomogr 2016;10:480\u20134. https:\/\/doi.org\/10.1016\/j.jcct.2016.08.004.","DOI":"10.1016\/j.jcct.2016.08.004"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_020_w2aab3b7c65b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Van den Hoven, AT, Chelu, RG, Duijnhouwer, AL, Demulier, L, Devos, D, Nieman, K, et al. Partial anomalous pulmonary venous return in Turner syndrome. Eur J Radiol 2017;95:141\u20136. https:\/\/doi.org\/10.1016\/j.ejrad.2017.07.024.","DOI":"10.1016\/j.ejrad.2017.07.024"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_021_w2aab3b7c65b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Mortensen, KH, Young, L, De Backer, J, Silberbach, M, Collins, RT, Duijnhouwer, AL, et al. Cardiovascular imaging in Turner syndrome: state-of-the-art practice across the lifespan. Heart 2018;104:1823\u201331. https:\/\/doi.org\/10.1136\/heartjnl-2017-312658.","DOI":"10.1136\/heartjnl-2017-312658"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_022_w2aab3b7c65b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Aligeti, VR, Horn, HR. Turner\u2019s syndrome and coronary artery disease. Am J Cardiol 2007;99:741\u20132. https:\/\/doi.org\/10.1016\/j.amjcard.2006.10.027.","DOI":"10.1016\/j.amjcard.2006.10.027"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_023_w2aab3b7c65b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Gerlis, LM, Gatzoulis, M, Ho, SY, Sheppard, MN. Sudden unexpected cardiac death in a patient with Turner\u2019s syndrome. Cardiol Young 2004;14:192\u20136. https:\/\/doi.org\/10.1017\/S1047951104002124.","DOI":"10.1017\/S1047951104002124"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_024_w2aab3b7c65b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Salgin, B, Amin, R, Yuen, K, Williams, RM, Murgatroyd, P, Dunger, DB. Insulin resistance is an intrinsic defect independent of fat mass in women with Turner\u2019s syndrome. Horm Res 2006;65:69\u201375. https:\/\/doi.org\/10.1159\/000090907.","DOI":"10.1159\/000090907"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_025_w2aab3b7c65b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Kozlowska-Wojciechowska, M, Jez, W, Zdrojewski, T, Chwojnicki, K. Are young women with Turner syndrome at greater risk of coronary artery disease?. Eur J Cardiovasc Prev Rehabil 2006;13:467\u20139. https:\/\/doi.org\/10.1097\/01.hjr.0000216545.99807.fd.","DOI":"10.1097\/00149831-200606000-00026"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_026_w2aab3b7c65b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Gravholt, CH, Mortensen, KH, Andersen, NH, Ibsen, L, Ingerslev, J, Hjerrild, BE. Coagulation and fibrinolytic disturbances are related to carotid intima thickness and arterial blood pressure in Turner syndrome. Clin Endocrinol (Oxf). 2012;76:649\u201356. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04190.x.","DOI":"10.1111\/j.1365-2265.2011.04190.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_027_w2aab3b7c65b1b6b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"Bondy, CA, Ceniceros, I, Van, PL, Bakalov, VK, Rosing, DR. Prolonged rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner syndrome. Pediatrics 2006;118:e1220\u20135. https:\/\/doi.org\/10.1542\/peds.2006-0776.","DOI":"10.1542\/peds.2006-0776"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_028_w2aab3b7c65b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Bondy, CA, Van, PL, Bakalov, VK, Sachdev, V, Malone, CA, Ho, VB, et al. Prolongation of the cardiac QTc interval in Turner syndrome. Medicine (Baltimore) 2006;85:75\u201381. https:\/\/doi.org\/10.1097\/01.md.0000205629.16302.bc.","DOI":"10.1097\/01.md.0000205629.16302.bc"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_029_w2aab3b7c65b1b6b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"Sozen, AB, Cefle, K, Kudat, H, Ozturk, S, Oflaz, H, Pamukcu, B, et al. Atrial and ventricular arryhthmogenic potential in Turner syndrome. Pacing Clin Electrophysiol 2008;31:1140\u20135. https:\/\/doi.org\/10.1111\/j.1540-8159.2008.01154.x.","DOI":"10.1111\/j.1540-8159.2008.01154.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_030_w2aab3b7c65b1b6b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"Golzio, PG, Franco, E, Chiribiri, A. Atrio-ventricular synchronization by single VDD lead inserted through persistent left superior vena cava in patient with Turner\u2019s syndrome. Pacing Clin Electrophysiol 2006;29:1181\u20132. https:\/\/doi.org\/10.1111\/j.1540-8159.2006.00513.x.","DOI":"10.1111\/j.1540-8159.2006.00513.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_031_w2aab3b7c65b1b6b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"Mortensen, KH, Gopalan, D, N\u00f8rgaard, BL, Andersen, NH, Gravholt, CH. Multimodality cardiac imaging in Turner syndrome. Cardiol Young 2016;26:831\u201341. https:\/\/doi.org\/10.1017\/S1047951115002735.","DOI":"10.1017\/S1047951115002735"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_032_w2aab3b7c65b1b6b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"Somerville, S, Rosolowsky, E, Suntratonpipat, S, Girgis, R, Goot, BH, Tham, EB. Cardiac magnetic resonance imaging in pediatric turner syndrome. J Pediatr 2016;175:111\u20135.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.04.080.","DOI":"10.1016\/j.jpeds.2016.04.080"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_033_w2aab3b7c65b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Obara-Moszynska, M, Rajewska-Tabor, J, Rozmiarek, S, Karmelita-Katulska, K, Kociemba, A, Rabska-Pietrzak, B, et al. The usefulness of magnetic resonance imaging of the cardiovascular system in the diagnostic work-up of patients with turner syndrome. Front Endocrinol (Lausanne) 2018;9:609. https:\/\/doi.org\/10.3389\/fendo.2018.00609.","DOI":"10.3389\/fendo.2018.00609"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_034_w2aab3b7c65b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"Arnold, R, Neu, M, Hirtler, D, Gimpel, C, Markl, M, Geiger, J. Magnetic resonance imaging 4-D flow-based analysis of aortic hemodynamics in Turner syndrome. Pediatr Radiol 2017;47:382\u201390. https:\/\/doi.org\/10.1007\/s00247-016-3767-8.","DOI":"10.1007\/s00247-016-3767-8"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_035_w2aab3b7c65b1b6b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"Sacc\u00e0, L, Cittadini, A, Fazio, S. Growth hormone and the heart. Endocr Rev 1994;15:555\u201373. https:\/\/doi.org\/10.1210\/edrv-15-5-555.","DOI":"10.1210\/edrv-15-5-555"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_036_w2aab3b7c65b1b6b1ab2b1c36Aa","doi-asserted-by":"crossref","unstructured":"Devesa, J, Almengl\u00f3, C, Devesa, P. Multiple effects of growth hormone in the body: is it really the hormone for growth?. Clin Med Insights Endocrinol Diabetes 2016;9:47\u201371. https:\/\/doi.org\/10.4137\/CMED.S38201.","DOI":"10.4137\/CMED.S38201"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_037_w2aab3b7c65b1b6b1ab2b1c37Aa","doi-asserted-by":"crossref","unstructured":"Li, Q, Li, B, Wang, X, Leri, A, Jana, KP, Liu, Y, et al. Overexpression of insulin-like growth factor-I in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress and cardiac hypertrophy. J Clin Invest 1997;100:1991\u20139. https:\/\/doi.org\/10.1172\/JCI119730.","DOI":"10.1172\/JCI119730"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_038_w2aab3b7c65b1b6b1ab2b1c38Aa","doi-asserted-by":"crossref","unstructured":"Timsit, J, Riou, B, Bertherat, J, Wisnewsky, C, Kato, NS, Weisberg, AS, et al. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest 1990;86:507\u201315. https:\/\/doi.org\/10.1172\/JCI114737.","DOI":"10.1172\/JCI114737"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_039_w2aab3b7c65b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"Cittadini, A, Ishiguro, Y, Str\u00f6mer, H, Spindler, M, Moses, AC, Clark, R, et al. Insulin-like growth factor-1 but not growth hormone augments mammalian myocardial contractility by sensitizing the myofilament to Ca2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ Res 1998;83:50\u20139. https:\/\/doi.org\/10.1161\/01.res.83.1.50.","DOI":"10.1161\/01.RES.83.1.50"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_040_w2aab3b7c65b1b6b1ab2b1c40Aa","doi-asserted-by":"crossref","unstructured":"Br\u00fcel, A, Oxlund, H. Biosynthetic growth hormone increase the collagen deposition rate in rat aorta and heart. Eur J Endocrinol 1995;132:195\u20139. https:\/\/doi.org\/10.1530\/eje.0.1320195.","DOI":"10.1530\/eje.0.1320195"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_041_w2aab3b7c65b1b6b1ab2b1c41Aa","doi-asserted-by":"crossref","unstructured":"Longobardi, S, Cuocolo, A, Merola, B, Di Rella, F, Colao, A, Nicolai E, et al. Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency. Clin Endocrinol (Oxf). 1998;48:137\u201343. https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00281.x.","DOI":"10.1046\/j.1365-2265.1998.00281.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_042_w2aab3b7c65b1b6b1ab2b1c42Aa","doi-asserted-by":"crossref","unstructured":"Valcavi, R, Gaddi, O, Zini, M, lavicoli, M, Mellino, U, Portioli, I. Cardiac performance and mass in adult with hypopituitarism: effects of one year of growth treatment. J Clin Endocrinol Metab 1995;80:659\u201366. https:\/\/doi.org\/10.1210\/jcem.80.2.7852533.","DOI":"10.1210\/jcem.80.2.7852533"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_043_w2aab3b7c65b1b6b1ab2b1c43Aa","doi-asserted-by":"crossref","unstructured":"Johannsson, G, Bengtsson, BA, Andersson, B, Isgaard, J, Caidahl, K. Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults: preliminary data in a small group of patients. Clin Endocrinol (Oxf). 1996;45:305\u201314. https:\/\/doi.org\/10.1046\/j.1365-2265.1996.00820.x.","DOI":"10.1046\/j.1365-2265.1996.00820.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_044_w2aab3b7c65b1b6b1ab2b1c44Aa","doi-asserted-by":"crossref","unstructured":"Cuneo, RC, Salomon, F, Wiles, CM, Hesp, R, S\u00f6nksen, PH. Growth hormone treatment in growth hormone deficient adults. I. Effects on muscle mass and strength. J Appl Physiol 1991;70:688\u201394. https:\/\/doi.org\/10.1152\/jappl.1991.70.2.688.","DOI":"10.1152\/jappl.1991.70.2.688"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_045_w2aab3b7c65b1b6b1ab2b1c45Aa","doi-asserted-by":"crossref","unstructured":"Castellano, G, Affuso, F, Di Conza, P, Fazio, S. The GH\/IGF-1 Axis and heart failure. Curr Cardiol Rev 2009;5:203\u201315. https:\/\/doi.org\/10.2174\/157340309788970306.","DOI":"10.2174\/157340309788970306"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_046_w2aab3b7c65b1b6b1ab2b1c46Aa","doi-asserted-by":"crossref","unstructured":"Caicedo, D, D\u00edaz, O, Devesa, P, Devesa, J. Growth hormone (GH) and cardiovascular system. Int J Mol Sci 2018;19:290. https:\/\/doi.org\/10.3390\/ijms19010290.","DOI":"10.3390\/ijms19010290"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_047_w2aab3b7c65b1b6b1ab2b1c47Aa","doi-asserted-by":"crossref","unstructured":"Lie, JT. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 1980;100:41\u201352. https:\/\/doi.org\/10.1016\/0002-8703(80)90277-x.","DOI":"10.1016\/0002-8703(80)90277-X"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_048_w2aab3b7c65b1b6b1ab2b1c48Aa","doi-asserted-by":"crossref","unstructured":"Sacc\u00e0, L, Napoli, R, Cittadini, A. Growth hormone, acromegaly, and heart failure: an intricate triangulation. Clin Endocrinol (Oxf). 2003;59:660\u201371. https:\/\/doi.org\/10.1046\/j.13652265.2003.01780.x.","DOI":"10.1046\/j.1365-2265.2003.01780.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_049_w2aab3b7c65b1b6b1ab2b1c49Aa","doi-asserted-by":"crossref","unstructured":"Freestone, NS, Ribaric, S, Mason, WT. The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Mol Cell Biochem 1996;163\u2013164:223\u20139. https:\/\/doi.org\/10.1007\/bf00408662.","DOI":"10.1007\/BF00408662"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_050_w2aab3b7c65b1b6b1ab2b1c50Aa","doi-asserted-by":"crossref","unstructured":"Mizera, \u0141, Elbaum, M, Daroszewski, J, Bolanowski, M. Cardiovascular complications of acromegaly. Acta Endocrinol (Buchar). 2018;14:365\u201374. https:\/\/doi.org\/10.4183\/aeb.2018.365.","DOI":"10.4183\/aeb.2018.365"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_051_w2aab3b7c65b1b6b1ab2b1c51Aa","doi-asserted-by":"crossref","unstructured":"Bondanelli, M, Ambrosio, MR, degli Uberti, EC. Pathogenesis and prevalence of hypertension in acromegaly. Pituitary 2001;4:239\u201349. https:\/\/doi.org\/10.1023\/a:1020798430884.","DOI":"10.1023\/A:1020798430884"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_052_w2aab3b7c65b1b6b1ab2b1c52Aa","doi-asserted-by":"crossref","unstructured":"Kamenick\u00fd, P, Mazziotti, G, Lomb\u00e8s, M, Giustina, A, Chanson, P. Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr Rev 2014;35:234\u201381. https:\/\/doi.org\/10.1210\/er.2013-1071.","DOI":"10.1210\/er.2013-1071"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_053_w2aab3b7c65b1b6b1ab2b1c53Aa","doi-asserted-by":"crossref","unstructured":"Spiliotis, BE. Recombinant human growth hormone in the treatment of Turner syndrome. Therapeut Clin Risk Manag 2008;4:1177\u201383. https:\/\/doi.org\/10.2147\/tcrm.s1440.","DOI":"10.2147\/TCRM.S1440"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_054_w2aab3b7c65b1b6b1ab2b1c54Aa","doi-asserted-by":"crossref","unstructured":"Reiter, EO, Blethen, SL, Baptista, J, Price, L. Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner\u2019s syndrome. J Clin Endocrinol Metab 2001;86:1936\u201341. https:\/\/doi.org\/10.1210\/jcem.86.5.7466.","DOI":"10.1210\/jc.86.5.1936"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_055_w2aab3b7c65b1b6b1ab2b1c55Aa","doi-asserted-by":"crossref","unstructured":"Linglart, A, Cabrol, S, Berlier, P, Stuckens, C, Wagner, K, de Kerdanet, M, et al. Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome. Eur J Endocrinol 2011;164:891\u20137. https:\/\/doi.org\/10.1530\/EJE-10-1048.","DOI":"10.1530\/EJE-10-1048"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_056_w2aab3b7c65b1b6b1ab2b1c56Aa","doi-asserted-by":"crossref","unstructured":"Gravholt, CH, Andersen, NH, Conway, GS, Dekkers, OM, Geffner, ME, Klein, KO, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol 2017;177:G1\u2013G70. https:\/\/doi.org\/10.1530\/EJE-17-0430.","DOI":"10.1530\/EJE-17-0430"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_057_w2aab3b7c65b1b6b1ab2b1c57Aa","doi-asserted-by":"crossref","unstructured":"Van Pareren, YK, de Muinck Keizer-Schrama, SM, Stijnen, T, Sas, TC, Jansen, M, Otten, BJ, et al. Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 2003;88:1119\u201325. https:\/\/doi.org\/10.1210\/jc.2002-021171.","DOI":"10.1210\/jc.2002-021171"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_058_w2aab3b7c65b1b6b1ab2b1c58Aa","doi-asserted-by":"crossref","unstructured":"Bannink, EM, van Doorn, J, Stijnen, T, Drop, SL, de Muinck Keizer-Schrama, SM. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment. Clin Endocrinol (Oxf). 2006;65:310\u20139. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02594.x.","DOI":"10.1111\/j.1365-2265.2006.02594.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_059_w2aab3b7c65b1b6b1ab2b1c59Aa","doi-asserted-by":"crossref","unstructured":"Kohno, H, Igarashi, Y, Ozono, K, Ohyama, K, Ogawa, M, Osada, H, et al. Favorable impact of growth hormone treatment on cholesterol levels in turner syndrome. Clin Pediatr Endocrinol 2012;21:29\u201334. https:\/\/doi.org\/10.1297\/cpe.21.29.","DOI":"10.1297\/cpe.21.29"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_060_w2aab3b7c65b1b6b1ab2b1c60Aa","doi-asserted-by":"crossref","unstructured":"Van Pareren, YK, de Muinck Keizer-Schrama, SM, Stijnen, T, Sas, TC, Drop, SL. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome. J Clin Endocrinol Metab 2002;87:5442\u20138. https:\/\/doi.org\/10.1210\/jc.2002-020789.","DOI":"10.1210\/jc.2002-020789"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_061_w2aab3b7c65b1b6b1ab2b1c61Aa","doi-asserted-by":"crossref","unstructured":"Kappelgaard, AM, Laursen, T. The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age. Growth Hormone IGF Res 2011;21:305\u201313. https:\/\/doi.org\/10.1016\/j.ghir.2011.09.004.","DOI":"10.1016\/j.ghir.2011.09.004"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_062_w2aab3b7c65b1b6b1ab2b1c62Aa","doi-asserted-by":"crossref","unstructured":"Ostberg, JE, Thomas, EL, Hamilton, G, Attar, MJ, Bell, JD, Conway, GS. Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J Clin Endocrinol Metab 2005;90:2631\u20135. https:\/\/doi.org\/10.1210\/jc.2004-1939.","DOI":"10.1210\/jc.2004-1939"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_063_w2aab3b7c65b1b6b1ab2b1c63Aa","doi-asserted-by":"crossref","unstructured":"Cintron, D, Rodriguez-Gutierrez, R, Serrano, V, Latortue-Albino, P, Erwin, PJ, Murad, MH. Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with turner syndrome: a systematic review and meta-analysis. Endocrine 2017;55:366\u201375. https:\/\/doi.org\/10.1007\/s12020-016-1046-y.","DOI":"10.1007\/s12020-016-1046-y"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_064_w2aab3b7c65b1b6b1ab2b1c64Aa","doi-asserted-by":"crossref","unstructured":"Elsheikh, M, Hodgson, HJ, Wass, JA, Conway, GS. Hormone replacement therapy may improve hepatic function in women with Turner\u2019s syndrome. Clin Endocrinol (Oxf). 2001;55:227\u201331. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01321.x.","DOI":"10.1046\/j.1365-2265.2001.01321.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_065_w2aab3b7c65b1b6b1ab2b1c65Aa","doi-asserted-by":"crossref","unstructured":"Koulouri, O, Ostberg, J, Conway, GS. Liver dysfunction in Turner\u2019s syndrome: prevalence, natural history and effect of exogenous oestrogen. Clin Endocrinol (Oxf). 2008;69:306\u201310. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03203.x.","DOI":"10.1111\/j.1365-2265.2008.03203.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_066_w2aab3b7c65b1b6b1ab2b1c66Aa","doi-asserted-by":"crossref","unstructured":"Bannink, EM, van der Palen, RL, Mulder, PG, de Muinck Keizer-Schrama, SM. Long-term follow-up of GH-treated girls with Turner syndrome: BMI, blood pressure, body proportions. Horm Res 2009;71:336\u201342. https:\/\/doi.org\/10.1159\/000223418.","DOI":"10.1159\/000223418"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_067_w2aab3b7c65b1b6b1ab2b1c67Aa","doi-asserted-by":"crossref","unstructured":"Sas, TC, Cromme-Dijkhuis, AH, de Muinck Keizer-Schrama, SM, Stijnen, T, van Teunenbroek, A, Drop, SL. The effects of long-term growth hormone treatment on cardiac left ventricular dimensions and blood pressure in girls with Turner\u2019s syndrome. Dutch Working Group on Growth Hormone. J Pediatr 1999;135:470\u20136. https:\/\/doi.org\/10.1016\/s0022-3476(99)70170-8.","DOI":"10.1016\/S0022-3476(99)70170-8"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_068_w2aab3b7c65b1b6b1ab2b1c68Aa","doi-asserted-by":"crossref","unstructured":"Van den Berg, J, Bannink, EM, Wielopolski, PA, Pattynama, PM, de Muinck Keizer-Schrama, SM, Helbing, WA. Aortic distensibility and dimensions and the effects of growth hormone treatment in the turner syndrome. Am J Cardiol 2006;97:1644\u20139. https:\/\/doi.org\/10.1016\/j.amjcard.2005.12.058.","DOI":"10.1016\/j.amjcard.2005.12.058"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_069_w2aab3b7c65b1b6b1ab2b1c69Aa","doi-asserted-by":"crossref","unstructured":"Irzyniec, T, Je\u017c, W, Lepska, K, Maciejewska-Paszek, I, Frelich, J. Childhood growth hormone treatment in women with Turner syndrome - benefits and adverse effects. Sci Rep 2019;9:15951. https:\/\/doi.org\/10.1038\/s41598-019-52332-0.","DOI":"10.1038\/s41598-019-52332-0"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_070_w2aab3b7c65b1b6b1ab2b1c70Aa","doi-asserted-by":"crossref","unstructured":"Baronio, F, Mazzanti, L, Girtler, Y, Tamburrino, F, Lupi, F, Longhi, S, et al. The influence of GH treatment on glucose homeostasis in girls with turner syndrome: a 7-year study. J Clin Endocrinol Metab 2017;102:878\u201383. https:\/\/doi.org\/10.1210\/jc.2016-3179.","DOI":"10.1210\/jc.2016-3179"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_071_w2aab3b7c65b1b6b1ab2b1c71Aa","doi-asserted-by":"crossref","unstructured":"Wooten, N, Bakalov, VK, Hill, S, Bondy, CA. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome. J Clin Endocrinol Metab 2008;93:2109\u201314. https:\/\/doi.org\/10.1210\/jc.2007-2266.","DOI":"10.1210\/jc.2007-2266"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_072_w2aab3b7c65b1b6b1ab2b1c72Aa","doi-asserted-by":"crossref","unstructured":"Mazzanti, L, Bergamaschi, R, Castiglioni, L, Zappulla, F, Pirazzoli, P, Cicognani, A. Turner syndrome, insulin sensitivity and growth hormone treatment. Horm Res 2005;64:51\u20137. https:\/\/doi.org\/10.1159\/000089318.","DOI":"10.1159\/000089318"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_073_w2aab3b7c65b1b6b1ab2b1c73Aa","doi-asserted-by":"crossref","unstructured":"Guttmann, H, Weiner, Z, Nikolski, E, Ish-Shalom, S, Itskovitz-Eldor, J, Aviram, M, et al. Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol (Oxf) 2001;54:159\u201364. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01181.x.","DOI":"10.1046\/j.1365-2265.2001.01181.x"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_074_w2aab3b7c65b1b6b1ab2b1c74Aa","doi-asserted-by":"crossref","unstructured":"Naeraa, RW, Gravholt, CH, Kastrup, KW, Svenstrup, B, Christiansen, JS. Morning versus evening administration of estradiol to girls with turner syndrome receiving growth hormone: impact on growth hormone and metabolism. A randomized placebo-controlled crossover study. Acta Paediatr 2001;90:526\u201331 https:\/\/doi.org\/10.1111\/j.1651-2227.2001.tb00793.x.","DOI":"10.1080\/080352501750197665"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_075_w2aab3b7c65b1b6b1ab2b1c75Aa","doi-asserted-by":"crossref","unstructured":"U\u00e7ar, A, Tu\u011frul, M, Erol, BO, Yekeler, E, Aydin, B, Yildiz, S, et al. Determinants of increased aortic diameters in young normotensive patients with turner syndrome without structural heart disease. Pediatr Cardiol 2018;39:786\u201393. https:\/\/doi.org\/10.1007\/s00246-018-1821-z.","DOI":"10.1007\/s00246-018-1821-z"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_076_w2aab3b7c65b1b6b1ab2b1c76Aa","doi-asserted-by":"crossref","unstructured":"Lopez, L, Arheart, KL, Colan, SD, Stein, NS, Lopez-Mitnik, G, Lin, AE, et al. Turner syndrome is an independent risk factor for aortic dilation in the young. Pediatrics 2008;121:e1622\u20137. https:\/\/doi.org\/10.1542\/peds.2007-2807.","DOI":"10.1542\/peds.2007-2807"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_077_w2aab3b7c65b1b6b1ab2b1c77Aa","doi-asserted-by":"crossref","unstructured":"Duijnhouwer, AL, Bons, LR, Timmers, HJ, van Kimmenade, RR, Snoeren, M, Timmermans, J, et al. Aortic dilatation and outcome in women with Turner syndrome. Heart 2019;105:693\u2013700. https:\/\/doi.org\/10.1136\/heartjnl-2018-313716.","DOI":"10.1136\/heartjnl-2018-313716"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_078_w2aab3b7c65b1b6b1ab2b1c78Aa","doi-asserted-by":"crossref","unstructured":"Alami Laroussi, N, Dahdah, N, Dallaire, F, Therien, J, Fournier, A. Aortic dilatation in patients with Turner\u2019s syndrome without structural cardiac anomaly. Cardiol Young 2016;26:539\u201346. https:\/\/doi.org\/10.1017\/S1047951115000682.","DOI":"10.1017\/S1047951115000682"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_079_w2aab3b7c65b1b6b1ab2b1c79Aa","doi-asserted-by":"crossref","unstructured":"Bondy, CA, Van, PL, Bakalov, VK, Ho, VB. Growth hormone treatment and aortic dimension in Turner syndrome. J Clin Endocrinol Metab 2006;91:1785\u20138. https:\/\/doi.org\/10.1210\/jc.2005-2625.","DOI":"10.1210\/jc.2005-2625"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_080_w2aab3b7c65b1b6b1ab2b1c80Aa","doi-asserted-by":"crossref","unstructured":"Matura, LA, Sachdev, V, Bakalov, VK, Rosing, DR, Bondy, CA. Growth hormone treatment and left ventricular dimensions in Turner syndrome. J Pediatr 2007;150:587\u201391. https:\/\/doi.org\/10.1016\/j.jpeds.2007.02.009.","DOI":"10.1016\/j.jpeds.2007.02.009"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_081_w2aab3b7c65b1b6b1ab2b1c81Aa","doi-asserted-by":"crossref","unstructured":"Shulman, DI, Root, AW, Diamond, FB, Bercu, BB, Martinez, R, Boucek, RJJr. Effects of one year of recombinant human growth hormone (GH) therapy on cardiac mass and function in children with classical GH deficiency. J Clin Endocrinol Metab 2003;88:4095\u20139. https:\/\/doi.org\/10.1210\/jc.2003-030030.","DOI":"10.1210\/jc.2003-030030"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_082_w2aab3b7c65b1b6b1ab2b1c82Aa","doi-asserted-by":"crossref","unstructured":"Radetti, G, Crepaz, R, Paganini, C, Gentili, L, Pitscheider, W. Medium-term cardiovascular effects of high-dose growth hormone treatment in growth hormone-deficient children. Horm Res 1999;52:247\u201352. https:\/\/doi.org\/10.1159\/000023469.","DOI":"10.1159\/000023469"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_083_w2aab3b7c65b1b6b1ab2b1c83Aa","doi-asserted-by":"crossref","unstructured":"Van den Berg, J, Bannink, EM, Wielopolski, PA, Hop, WC, van Osch-Gevers, L, Pattynama, PM, et al. Cardiac status after childhood growth hormone treatment of Turner syndrome. J Clin Endocrinol Metab 2008;93:2553\u20138. https:\/\/doi.org\/10.1210\/jc.2007-2313.","DOI":"10.1210\/jc.2007-2313"},{"key":"2023040101055754481_j_jpem-2020-0266_ref_084_w2aab3b7c65b1b6b1ab2b1c84Aa","doi-asserted-by":"crossref","unstructured":"Takano, K, Hizuka, N, Shizume, K. Treatment of Turner\u2019s syndrome with methionyl human growth hormone for six months. Acta Endocrinol (Copenh) 1986;112:130\u20137. https:\/\/doi.org\/10.1530\/acta.0.1120130.","DOI":"10.1530\/acta.0.1120130"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/jpem\/33\/11\/article-p1363.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2020-0266\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2020-0266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T18:08:28Z","timestamp":1680372508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2020-0266\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":84,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,10,23]]},"published-print":{"date-parts":[[2020,11,26]]}},"alternative-id":["10.1515\/jpem-2020-0266"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2020-0266","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,12]]}}}